Evidence map›Paper›PMID 40571807›Full record

ArticleMikrochimica acta2025

Flexible, self-standing 3D Nb

Divyasri Ramasamy, Sushmee Badhulika

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Divyasri RamasamyCenter for Interdisciplinary Programs, Indian Institute of Technology, Hyderabad, 502284, India.
Sushmee BadhulikaCenter for Interdisciplinary Programs, Indian Institute of Technology, Hyderabad, 502284, India. sbadh@ee.iith.ac.in.

Funding

Department of Science and Technology DST/TDT/AM/2022/420
6 · The paper itself

Abstract

Various analytical techniques are available for the detection of antituberculosis drug delamanid (DLM), whose unregulated dosage can lead to severe health issues. To date, electrochemical sensing of delamanid remains unexplored. In this work, we demonstrate that niobium pentoxide (Nb

Indexed as

Antitubercular AgentsElectrochemical TechniquesHydrogelsMetal-Organic FrameworksNiobiumNitroimidazolesOxidesAluminumElectrodesHumansLimit of DetectionNanocompositesAluminumAntitubercular AgentsHydrogelsMetal-Organic FrameworksNiobiumNitroimidazolesOxidesAntituberculosis drugElectrochemical sensingHydrogel-derived foamMetal–organic framework (MOF)Nb2O5

Identifiers

PMID40571807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.